|
|
-
Federman & Sherwood Says A Securities Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc.
5/12/2013
|
-
RBC Capital Markets Downgrades AVEO Pharmaceuticals, Inc. (AVEO) To Sector Perform From Outperform With $6 down from $15 Price Target
5/3/2013
|
|
|
|
|
|
|
|
|
|
|
-
Trading Of AVEO Stock Halted; FDA Advisory Committee To Review Tivozanib For Advanced Renal Cell Carcinoma Treatment
5/2/2013
|
|
|